Offer - Urjas Oil for just ₹ 1 X
Nevirin NT Tablet is an allopathic medicine The correct dosage of Nevirin NT Tablet depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Nevirin NT Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Nevirin NT Tablet safe for pregnant women?
Nevirin NT Tablet is safe to take during pregnancy.
Is the use of Nevirin NT Tablet safe during breastfeeding?
Nevirin NT Tablet is completely safe for breastfeeding women.
What is the effect of Nevirin NT Tablet on the Kidneys?
Nevirin NT Tablet can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Nevirin NT Tablet on the Liver?
Nevirin NT Tablet is rarely harmful for the liver.
What is the effect of Nevirin NT Tablet on the Heart?
Nevirin NT Tablet may have mild side effects on the heart. Most people will never see any effect on the heart.
Nevirin NT Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Nevirin NT Tablet unless your doctor advises you to do so -
Is this Nevirin NT Tablet habit forming or addictive?
Nevirin NT Tablet is not addictive in nature.
Interaction between Food and Nevirin NT Tablet
Eating certain foods may increase the time it takes Nevirin NT Tablet to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Nevirin NT Tablet
Information about the interaction of Nevirin NT Tablet and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 924-925
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pamelor® (nortriptyline hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lyrica (pregabalin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1048-1049
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420